Clinical Trial

Performance of Systane PRO Versus Refresh Optive Mega-3

Terminated Phase 4
View on ClinicalTrials.gov →
Why the trial stopped
investigator decision
Summary
Single site, prospective, double-masked, randomized-controlled, cross-over study of the subjective and objective performance of 2 different eyedrops. Subjects will be assessed at a screening visit, and 3 follow-up visits. Clinical evaluations will include patient questionnaires.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-08; most recent amendment 2026-04-08.
Status change: Recruiting → Terminated 2026-04-08
Trial Details
NCT Number NCT06975891
Lead Sponsor Scripps Poway Eyecare and Optometry
Collaborators: Sengi
Conditions Dry Eye
Enrollment 20 participants
Start Date 2025-05-15
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-13